Aton (EPA:ALTAO)

France flag France · Delayed Price · Currency is EUR
0.0060
+0.0002 (3.45%)
At close: Mar 6, 2026
-36.17%
Market Cap 4.97M
Revenue (ttm) 656.93K
Net Income (ttm) -115.68K
Shares Out 828.12M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,785,477
Average Volume 626,217
Open 0.0058
Previous Close 0.0058
Day's Range 0.0058 - 0.0066
52-Week Range 0.0050 - 0.0108
Beta 0.12
RSI 48.70
Earnings Date Apr 30, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9
Stock Exchange Euronext Paris
Ticker Symbol ALTAO
Full Company Profile

Financial Performance

In 2024, Aton's revenue was 614,000, an increase of 0.33% compared to the previous year's 612,000. Losses were -1.10 million, -86.01% less than in 2023.

Financial Statements

News

There is no news available yet.